Hata, Shinnosuke
Ushigome, Emi
Hosomi, Yukako
Yoshimura, Takashi
Takegami, Maya
Kitagawa, Nobuko
Tanaka, Toru
Hasegawa, Goji
Ohnishi, Masayoshi
Tsunoda, Sei
Ushigome, Hidetaka
Asano, Mai
Hamaguchi, Masahide
Yamazaki, Masahiro
Fukui, Michiaki
Article History
Received: 30 June 2022
Accepted: 21 November 2022
First Online: 11 January 2023
Compliance with ethical standards
:
: SH reports personal fees from Kowa Pharmaceutical Company Ltd., outside the submitted work. EU received grant support from the Japan Society for the Promotion of Science and received personal fees from Nippon Boehringer Ingelheim Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company, Limited, Takeda Pharmaceutical Company Ltd., MSD K.K., Kyowa Hakko Kirin Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Kowa Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., AstraZeneca K.K., and Sanofi K.K., outside the submitted work. The donated fund laboratory of diabetes therapeutics is an endowment department supported by an unrestricted grant from Ono Pharmaceutical Co., Ltd., Taiyo Kagaku Co., Ltd. and Taisho Pharmaceutical Co., Ltd. TY reports personal fees from Sumitomo Dainippon Pharma Co., Ltd., outside the submitted work. Isao Yokota reports grants from Kakenhi, Amed, and Health, Labor and Welfare Policy Research Grants, research funding by Nihon Medi-Physics, and speaker fees from Chugai Pharmaceutical Co, AstraZeneca plt, Japan Tobacco Pharmaceutical Division, and Nippon Shinyaku Co., outside the submitted work. MA received personal fees from Takeda Pharmaceutical Co., Ltd., Abbott Japan Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Kowa Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., AstraZeneca K.K., and Chugai Pharmaceutical Co., Ltd., outside the submitted work. MH received grants from AstraZeneca K.K., Ono Pharma Co. Ltd., Oishi Kenko Inc., Yamada Bee Farm, Nippon Boehringer Ingelheim Co. Ltd., and received personal fees from AstraZeneca K.K., Ono Pharma Co. Ltd., Eli Lilly, Japan, Sumitomo Dainippon Pharma Co., Ltd., Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Corp., Sanofi K.K., Kowa Pharma Co. Ltd., outside the submitted work. MY reports personal fees from MSD K.K., personal fees from Sumitomo Dainippon Pharma Co., Ltd.; personal fees from Kowa Company, Limited; personal fees from AstraZeneca PLC; personal fees from Takeda Pharmaceutical Company Limited; personal fees from Kyowa Hakko Kirin Co., Ltd.; personal fees from Daiichi Sankyo Company, Limited; personal fees from Kowa Pharmaceutical Company Ltd.; and personal fees from Ono Pharmaceutical Co., LTD., outside the submitted work. Michiaki Fukui received grants from Ono Pharma Co. Ltd., Oishi Kenko Inc., Yamada Bee Farm, Nippon Boehringer Ingelheim Co. Ltd., Kissei Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corp., Daiichi Sankyo Co. Ltd., Sanofi K.K., Takeda Pharma Co. Ltd., Astellas Pharma Inc., MSD K.K., Kyowa Kirin Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Kowa Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Sanwa Kagagu Kenkyusho CO., Ltd., Eli Lilly, Japan, K.K., Taisho Pharma Co., Ltd., Terumo Corp., Tejin Pharma Ltd., Nippon Chemiphar Co., Ltd., Abbott Japan Co. Ltd., and Johnson & Johnson K.K. Medical Co., Terumo Corporation, and received personal fees from Nippon Boehringer Ingelheim Co., Ltd., Kissei Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corp., Daiichi Sankyo Co. Ltd., Sanofi K.K., Takeda Pharma Co. Ltd., Astellas Pharma Inc., MSD K.K., Kyowa Kirin Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Kowa Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Ono Pharma Co. Ltd., Sanwa Kagaku Kenkyusho Co. Ltd., Eli Lilly Japan K.K., Taisho Pharma Co., Ltd., Bayer Yakuhin, Ltd., AstraZeneca K.K., Mochida Pharma Co. Ltd., Abbott Japan Co. Ltd., Teijin Pharma Ltd., Arkray Inc., Medtronic Japan Co. Ltd., and Nipro Corp., Terumo Corporation, outside the submitted work. The sponsors were not involved in the study design, collection, analysis, or interpretation of the data; the writing of this manuscript; or the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The authors declare that although they are affiliated with a department that is supported financially by a pharmaceutical company, the authors received no current funding for this study, and their department affiliation does not alter their adherence to all the full journal policies on sharing data and materials.